PATIENT SCENARIOS

Are your patients experiencing a dose gap during ADHD medication titration?

Some Patients May Benefit From a 45 mg,
63 mg, or 72 mg Tablet

Patients requiring an ADHD medication dose adjustment may benefit from additional dosing options that support personalized ADHD treatment.

These patient scenarios illustrate how RELEXXII may help address common ADHD medication dose adjustment and titration challenges.

See how RELEXXII may help solve a dose gap for personalized ADHD treatment

Not actual patient cases. Individual results may vary.

  • Name
    Andrew
  • Age
    11
  • Occ
    5th grader
  • Dx
    ADHD
  • Hyperactivity in school;
    initiated on
    methylphenidate HCl 18 mg
  • Titrated to 36 mg with
    inadequate symptom
    control; hesitant to increase
    to 54 mg due to the
    possibility of insomnia
HOW RELEXXII SOLVED THE DOSE GAP
  • Switched to once-daily RELEXXII 45 mg to help balance symptom management and tolerability
  • Parent reports reduced hyperactivity and improved homework focus; monitoring for common methylphenidate HCl side effects, e.g., growth suppression or nausea
  • Name
    Olivia
  • Age
    17
  • Occ
    12th grader
  • Dx
    ADHD
  • On methylphenidate HCl 36
    mg; symptoms intensified
    senior year with increasing
    academic demands
  • Titrated from 36 mg to 54
    mg; parent reported
    appetite suppression
HOW RELEXXII SOLVED THE DOSE GAP
  • Dose reduced by 9 mg to once-daily RELEXXII 45 mg; appetite improved while ADHD symptom control remained stable
  • No new adverse events reported; monitoring for common methylphenidate HCl side effects, e.g., insomnia or upper abdominal pain
  • Name
    Ellie
  • Age
    28
  • Occ
    Paralegal
  • Dx
    ADHD
  • Long-standing attention
    difficulties revealed by a
    more detail-intensive role
  • Diagnosed by a psychiatrist
    and initiated on
    methylphenidate HCl 36
    mg
HOW RELEXXII SOLVED THE DOSE GAP
  • Following titration from 54 mg to 72 mg, started feeling anxious, which disrupted work; 18 mg titration step not tolerated
  • Titrated down 9 mg to once-daily RELEXXII 63 mg; maintaining symptom improvement with ongoing monitoring for common methylphenidate HCl side effects e.g., addiction, restlessness, or appetite suppression
  • Name
    Eric
  • Age
    34
  • Occ
    Assembly line operator
  • Dx
    ADHD
  • ADHD diagnosed in
    adolescence; remained off
    stimulant therapy for several
    years
  • Clinical re-evaluation
    prompted by work demands
    and the need for ADHD
    symptom control; initiated
    methylphenidate HCl 36 mg
HOW RELEXXII SOLVED THE DOSE GAP
  • Titrated gradually to 72 mg (using two 36 mg tablets) once a day; 72 mg dose well tolerated
  • Transitioned to once-daily RELEXXII 72 mg to reduce pill burden; monitoring for common methylphenidate HCl side effects, e.g., abuse, hypertension, or headache

Before prescribing RELEXXII

Prior to initiating treatment with RELEXXII, assess patients for:

  • Cardiac disease, including a careful personal and family history of sudden death or ventricular arrhythmia and a physical examination1

  • Tourette’s syndrome, including motor or verbal tics or family history of Tourette’s syndrome1

Please see the full Prescribing Information for complete screening recommendations, warnings, and precautions
associated with RELEXXII.

Care partners reviewing RELEXXII savings resources

See the Technology Behind the Drug Delivery

Learn how RELEXXII’s extended-release design delivers methylphenidate throughout the day in a single tablet.

WATCH HOW RELEXXII WORKS

References: 1. RELEXXII package insert. Vertical Pharmaceuticals, LLC.

All individuals depicted are models used for illustrative purposes only.

ADHD=attention deficit hyperactivity disorder